Unknown

Dataset Information

0

Hypothermia augments neuroprotective activity of mesenchymal stem cells for neonatal hypoxic-ischemic encephalopathy.


ABSTRACT: Though hypothermia is the only clinically available treatment for neonatal hypoxic-ischemic encephalopathy (HIE), it is not completely effective in severe cases. We hypothesized that combined treatment with hypothermia and transplantation of human umbilical cord blood (UCB)-derived mesenchymal stem cells (MSCs) would synergistically attenuate severe HIE compared to stand-alone therapy. To induce hypoxia-ischemia (HI), male Sprague-Dawley rats were subjected to 8% oxygen for 120 min after unilateral carotid artery ligation on postnatal day (P) 7. After confirmation of severe HIE involving >50% of the ipsilateral hemisphere volume as determined by diffusion-weighted brain magnetic resonance imaging (MRI) within 2 h after HI, intraventricular MSC transplantation (1 × 105 cells) and/or hypothermia with target temperature at 32°C for 24 h were administered 6 h after induction of HI. Follow-up brain MRI at P12 and P42, sensorimotor function tests at P40-42, evaluation of cytokines in the cerebrospinal fluid (CSF) at P42, and histologic analysis of peri-infarct tissues at P42 were performed. Severe HI resulted in progressively increased brain infarction over time as assessed by serial MRI, increased number of cells positive for terminal deoxynucleotidyl transferase nick-end labeling, microgliosis and astrocytosis, increased CSF cytokine levels, and impaired function in behavioral tests such as rotarod and cylinder tests. All of the abnormalities observed in severe HIE showed greater improvement after combined treatment with hypothermia and MSC transplantation than with either therapy alone. Overall, these findings suggest that combined treatment with hypothermia and human UCB-derived MSC transplantation might be a novel therapeutic modality to improve the prognosis of severe HIE, an intractable disease that currently has no effective treatment.

SUBMITTER: Park WS 

PROVIDER: S-EPMC4376738 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature

altmetric image

Publications

Hypothermia augments neuroprotective activity of mesenchymal stem cells for neonatal hypoxic-ischemic encephalopathy.

Park Won Soon WS   Sung Se In SI   Ahn So Yoon SY   Yoo Hye Soo HS   Sung Dong Kyung DK   Im Geun Ho GH   Choi Soo Jin SJ   Chang Yun Sil YS  

PloS one 20150327 3


Though hypothermia is the only clinically available treatment for neonatal hypoxic-ischemic encephalopathy (HIE), it is not completely effective in severe cases. We hypothesized that combined treatment with hypothermia and transplantation of human umbilical cord blood (UCB)-derived mesenchymal stem cells (MSCs) would synergistically attenuate severe HIE compared to stand-alone therapy. To induce hypoxia-ischemia (HI), male Sprague-Dawley rats were subjected to 8% oxygen for 120 min after unilate  ...[more]

Similar Datasets

| S-EPMC9687213 | biostudies-literature
| S-EPMC4613313 | biostudies-literature
| S-EPMC5955959 | biostudies-literature
| S-EPMC3299861 | biostudies-other
| S-EPMC2897079 | biostudies-other
| S-EPMC4568393 | biostudies-literature
| S-SCDT-10_1038-S44321-024-00079-1 | biostudies-other
| S-EPMC8505668 | biostudies-literature
| S-EPMC3887346 | biostudies-literature
| S-EPMC4402201 | biostudies-literature